Dr Stock Pick HOT News & Alerts!

FREE Daily Stock Alerts From DrStockPick.com

Thursday May 06, 2010

DrStockPick.com Stock Report!

*****************

PWRM, Power 3 Medical Products Inc., PWRM.OB

Stem Cells are currently the most sophisticated area of our medical science, through their use the medical establishment hopes to be in a position to cure every disease and physical injury whether now known or yet to be discovered.

The science dealing with stem cells, which are master cells that are believed to be capable of regenerating every organ and tissue of the human body, is still considered to be in its infancy. Science is looking into a complimentary medium that will work along with stem cells to expedite re-growth and repair.

That complimentary medium is known as Extracellular matrix which is a component of body tissue that functions outside of the body’s cells. It’s made up mostly of collagen, a type of protein. So extracellular matrix extracted from the bladder of a pig does not actually have any of the pig’s cells in it.

Extracellular matrix, lays the framework that cells use to generate any given body part. It’s like a “cellular scaffolding”, and all animals have it. It holds the signals that direct cells to divide - differentiate and build themselves into a specific form.

In human fetuses, the substance works in concert with stem cells to grow and re-grow everything from heart aortas to toes. Fetuses can re-grow almost anything that gets damaged while in the womb.

Scientists have long believed that when a fetus reaches full development, this extracellular matrix stops functioning. But with evidence that applying extracellular matrix from a pig can initiate certain types of regeneration in humans, they’re wondering if they can trigger human extracellular matrix to start working again. After all, according to regeneration researcher Dr. Stephen Badylak of the University of Pittsburgh , children up to the age of two have been known to re-grow fingertips with no outside help.

Perhaps one day this extracellular matrix, coupled with further research in the use of stem cells will awaken this sleeping physical instinct.

Pig-extracted extracellular matrix is already used by veterinarians to help horses repair torn ligaments. In people, it’s used to treat ulcers, closing a hole in the tissue that lines the stomach. It employs an entirely different process than the typical mammalian healing mechanism. Let’s take the case of a person who loses the tip of a finger. When the finger is severed, the cells die, and their contents seep into the surrounding tissue. This alerts the immune system to a problem.

The immune system’s response to cell death is inflammation and scar tissue. The formation of scar tissue prevents any future cellular development in the area. That’s why scars last — cells are prevented from doing a repair job on that skin.

But when extracellular matrix is applied to a wound, it doesn’t trigger an immune response. Instead, when it begins to break down into surrounding tissue, it causes the cells in that tissue to start repairing the damage the way they would in a developing fetus (or a salamander that loses a limb) — they divide and rebuild, creating new, normal tissue, not scar tissue.

Combined with developments in stem-cell research, this extracellular matrix may work miracles in the area of regeneration science.

We have been watching one company that appears to be standing out in the crowd “PWRM”.

PWRM is a leader in bio-medical research and the commercialization of biomarkers, tests, and mechanisms of disease. PWRM’s patent-pending technologies are being used to develop screening and diagnostic tests for the early detection and prognosis of disease, identify protein biomarkers, and drug targets, to fulfill critical unmet needs in areas including neurodegenerative disease (NuroPro) and breast cancer (BC-SeraPro).

Last February, PWRM entered into a definitive merger agreement to acquire StemTroniX, Inc.

StemTroniX, Inc. is a stem cell biotechnology acquisition and holding company that is committed to improving the lives of individuals by using autologous adult stem cell technology to repair tissue damage in patients.

Autologous adult stem cell therapy is the process of using an individual’s own stem cells for the purpose of repairing and regenerating damaged tissue. StemTroniX also provides a patented system to augment this process in a non-invasive method for in-body monitoring of the stem cells at the site of injury as they are being introduced into the patients.

** PWRM and StemTroniX, Inc., have applied for a joint provisional patent application entitled “Stem Cell Protein Biomarkers and Their Use in Monitoring Stem Cells and Their Products for Stem Cell Therapy”

This application has been filed by the principals of StemTroniX and PWRM with the United States Patent and Trademark Office. It is anticipated to advance Stem Cell technologies, in the cure of disease and regenerative tissue and organ sciences.

It clearly claims in no uncertain terms how medical practices and scientific methods will enhance modern and future regenerative medicine technologies by precisely identifying the specific stem cells to be transplanted with protein biomarkers.

Stay tuned there is more, and all appears worth watching.

Keep a close eye on PWRM from now on!

More about PWRM at www.power3medical.com

**************************************************************

**************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. (read more) . Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) has previously received five hundred thousand shares compensation for 30 days of advertisement services and received an additional 1,000,000 shares 144 restricted stocks for a continuation of 6 months of advertisement and disseminating news, as well as $15,000 dollars for IR services for Power 3 Medical Products Inc. (PWRM.OB). Recently, Crown Equity Holdings, Inc has received an additional amount of 2,000,000 shares of free trading stock for 60 days media advertisement, web design and maintenance for Power 3 Medical Products Inc. (PWRM.OB).

Tags: Power 3 Medical Products, PWRM, PWRM.OB, Stem Cell Protein Biomarkers, Stem Cells, StemCells

This entry was posted on Thursday, May 6th, 2010 at 1:08 pm and is filed under Dr Stock Pick. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.